About Us

The Mount Sinai Hospital was recently ranked by Newsweek magazine as #2 in the world specializing in liver diseases and digestive diseases.

The goal of our liver specialists is to diagnose and treat your liver disease quickly and accurately to preserve your health. We focus on ensuring you can continue to live a full, active life. Our tradition of excellence in patient care, medical education, and research creates a collaborative approach to how we care for you. Together, we achieve our goal of providing the most effective and compassionate care. Our liver specialists (hepatologists) diagnose and treat liver disease. Supported by the research at the Icahn School of Medicine at Mount Sinai, we conduct Clinical Trials to continue discovering new ways to prevent and treat liver disease. We have specialized expertise in fatty liver disease (also known as Non-alcoholic fatty liver disease, or NAFLD, or its more advanced form, non-alcoholic steatohepatitis, or NASH) and are conducting groundbreaking research to find the best ways to diagnose and treat this very common condition. We are experts in viral hepatitis, B, C and Delta and all forms of autoimmune liver disease like PBC and PSC. Alcoholic liver disease is also an area of particular expertise. 

Our Early and Comprehensive Approach

We perform a comprehensive evaluation including in-office fibroscans to evaluate fat and fibrosis in the liver, and develop a treatment plan that helps slow or reverse your liver disease. Studies, including many of our own groundbreaking investigations, show that early, expert treatment can help limit complications and prevent end-stage liver disease. Timely treatment helps avoid potential complications that could require surgery or transplantation. We consult with colleagues and specialists throughout Mount Sinai to provide you with the most advanced interdisciplinary care. To do so, we work closely with key Mount Sinai specialists in surgery, radiology, and pathology. If your liver disease treatment requires hospitalization, you can receive treatment at one of Mount Sinai’s six hospitals in New York. Our liver disease doctors work with multidisciplinary treatment teams to ensure that we meet your needs during and after your hospital stay.

Mount Sinai Milestones in Liver Treatments

Mount Sinai has been a leader in the diagnosis and treatment of liver disease since 1957, when Hans Popper, MD, regarded as the father of hepatology, joined the Icahn School of Medicine at Mount Sinai faculty.

Our physicians and researchers have made discoveries and advances in many areas of liver disease, such as:

  • Conducted early clinical trials in the United States that generated the first effective oral medications for liver cancer
  • First to perform adult and pediatric living-donor liver transplants in New York State
  • First to perform a liver transplant in New York State
  • First to perform a multivisceral (stomach, small intestine, pancreas and liver) transplant in New York State
  • First to identify the cells responsible for liver fibrosis, which can lead to cirrhosis
  • Led clinical trials that enabled Food and Drug Administration (FDA) approval for a new class of drugs for hepatitis C that has a 95 percent cure rate
  • Led a key clinical trial that made possible the first FDA-approved treatment for patients with both hepatitis C and HIV
  • Established a NASH (non-alcoholic steatohepatitis) Center of Excellence to identify the most effective ways to diagnose and treat this condition

We Can Help You

Like many long-lasting diseases, chronic liver disease may not have a cure. However, through patient education and counseling, we help you manage your chronic liver disease and maximize your quality of life.

In addition, the medical treatments we provide for many liver diseases are fast becoming more and more effective. For some conditions, such as hepatitis C, we now talk in terms of a true cure in the vast majority of cases. Our hepatitis C specialists provide innovative treatments for hepatitis C. Our LEAP hepatitis C care coordinators provide comprehensive, personalized support services from your first appointment until cure.

For other conditions, such as hepatitis B, we can suppress the disease completely with medication and we are working hard on clinical trials that may lead to a “cure” of hepatitis B. Regardless of your age, gender, or level of activity, early diagnosis and aggressive treatment are critical to preserving your liver function and preventing liver failure. For NAFLD or NASH, we can apply the most advanced techniques of diagnosis and management, which are changing rapidly.